Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 11.05.2026 8 AIDS 1 AIDS Res Hum Retroviruses 1 Ann Intern Med 1 BMC Neurol 2 Clin Infect Dis 1 Drugs 4 HIV Med 4 J Acquir Immune Defic Syndr 2 J Clin Invest 2 J Infect Dis 1 J Med Virol 3 J Virol 1 Nat Med 1 Nat Rev Immunol 1 Nature 2 PLoS Med 7 PLoS One 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. ODONGPINY ELA, Otaalo B, Musaazi J, Nalugga EA, et al
   Risks and possible implications of weight gain after switch to dolutegravir- in a large Ugandan cohort of people living with HIV.
   AIDS. 2026 May 7. doi: 10.1097/QAD.0000000000004540.
   PubMed         Abstract available
   
   
2. LAKE JE, Kitch DW, Kantor A, Alonso C, et al
   Semaglutide improves markers of cardiovascular risk in people with HIV.
   AIDS. 2026 May 5. doi: 10.1097/QAD.0000000000004538.
   PubMed         Abstract available
   
   
3. MAFUTA C, Grabar S, Lievre L, Tran L, et al
   Factors associated with loss to follow-up among people living with HIV in France.
   AIDS. 2026 May 5. doi: 10.1097/QAD.0000000000004536.
   PubMed         Abstract available
   
   
4. STEPHEN ZR, Perazzolo S, Duan L, Eguchi M, et al
   A novel all-in-one injectable composed of tenofovir alafenamide-dolutegravir-lamivudine exhibits long-acting plasma and cell drug persistence for 8 weeks.
   AIDS. 2026 May 4. doi: 10.1097/QAD.0000000000004531.
   PubMed         Abstract available
   
   
5. FOSTER C, Blenkinsop A, Henderson M, Lyall H, et al
   Risk factors associated with adverse metabolic health in youth with perinatally acquired HIV living in the United Kingdom.
   AIDS. 2026 May 4. doi: 10.1097/QAD.0000000000004533.
   PubMed         Abstract available
   
   
6. ZHAO D, Sun L, Cen P, He Y, et al
   Renal outcomes with dolutegravir plus lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in ART-naive adults with HIV.
   AIDS. 2026 May 4. doi: 10.1097/QAD.0000000000004535.
   PubMed         Abstract available
   
   
7. AUGELLO M, Mingione A, Borghi L, Corona A, et al
   Astrocyte/monocyte activation and inflammation are associated with asymptomatic neurocognitive impairment in people with HIV on suppressive antiretroviral therapy.
   AIDS. 2026 May 4. doi: 10.1097/QAD.0000000000004534.
   PubMed         Abstract available
   
   
8. CAMARD M, Placais L, Bitu M, Mouanga C, et al
   Modulation of TLR-driven monocyte activation by JAK-STAT inhibitors in people with HIV.
   AIDS. 2026 May 4. doi: 10.1097/QAD.0000000000004530.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

9. HOCKNEY S, Mueller D, Phillbrick A, Berlet J, et al
   Real-World Patterns of Discontinuation and Virologic Failure with Long-Acting Cabotegravir-Rilpivirine.
   AIDS Res Hum Retroviruses. 2026 May 5:8892229261449867.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

10. KHALILI M, Haghdoost F, Liaghatdar A, Torabiardakani K, et al
    Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials.
    Ann Intern Med. 2026 May 5. doi: 10.7326/ANNALS-25-02221.
    PubMed         Abstract available
    
    

    
    BMC Neurol

11. NGUYEN BT, Nguyen-Cong HA, Nguyen MA, Duong MP, et al
    Hyponatremia as a "red flag" for concurrent meningitis in pulmonary cryptococcosis: a risk stratification model.
    BMC Neurol. 2026 Apr 20. doi: 10.1186/s12883-026-04904.
    PubMed        
    
    

    
    Clin Infect Dis

12. FONCILLAS A, Ambrosioni J, de la Mora L, Mallolas J, et al
    Atypical HBV Serological Patterns After Switching to CAB/RPV: Interpretation Within Current Definitions.
    Clin Infect Dis. 2026 May 7:ciag303. doi: 10.1093.
    PubMed        
    
    
13. ADACHI E, Yotsuyanagi H
    Anti-HBs Seroconversion Following Withdrawal of Anti-HBV-Active Agents: An Underrecognized Form of HBV Reactivation?
    Clin Infect Dis. 2026 May 7:ciag305. doi: 10.1093.
    PubMed        
    
    

    
    Drugs

14. WAGNER JA, Sandel DA, Deitchman AN, Rutishauser RL, et al
    Advances in Immune-Based Approaches for the Cure of HIV Infection.
    Drugs. 2026 May 2. doi: 10.1007/s40265-026-02311.
    PubMed         Abstract available
    
    

    
    HIV Med

15. SOLER-CARRACEDO A, Webel AR, Ramos-Ruperto L, Mican-Rivera R, et al
    Preference for different PrEP formulations: A cross-sectional study in a PrEP cohort in Spain.
    HIV Med. 2026 May 6. doi: 10.1111/hiv.70252.
    PubMed         Abstract available
    
    
16. EBASONE PV, Dzudie A, Peer N, Aseneh J, et al
    Prevalence of cardiometabolic diseases among ART-naive people with HIV: A global systematic review and meta-analysis.
    HIV Med. 2026 May 6. doi: 10.1111/hiv.70254.
    PubMed         Abstract available
    
    
17. NORTH S, Calderon-Cifuentes PA, Raben D, Bivol S, et al
    Monitoring the HIV response for trans people in Europe and Central Asia.
    HIV Med. 2026 May 6. doi: 10.1111/hiv.70250.
    PubMed         Abstract available
    
    
18. TANG TH, Kwong RT, Chan P, Lam KW, et al
    Real-world clinical and laboratory changes after switching to two-drug regimen in HIV-suppressed individuals: 48 weeks and beyond.
    HIV Med. 2026 May 4. doi: 10.1111/hiv.70247.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

19. HAY WONG JM, Lee T, Av-Gay G, Azampanah A, et al
    Developing a Preterm Birth Prediction Model in Pregnant People with HIV using a Population-Based Cohort.
    J Acquir Immune Defic Syndr. 2026 May 6. doi: 10.1097/QAI.0000000000003898.
    PubMed         Abstract available
    
    
20. KUNIHOLM MH, Murenzi G, Samala N, Yunihastuti E, et al
    Hepatitis B and C Prevention, Screening and Diagnostic Services at HIV Treatment Sites: International epidemiology Databases to Evaluate AIDS.
    J Acquir Immune Defic Syndr. 2026 May 5. doi: 10.1097/QAI.0000000000003896.
    PubMed         Abstract available
    
    
21. KIZITO S, Ssewamala FM, Nabayinda J, Nabunya P, et al
    Comparing Self-Reports, Pill Counts, and Electronic Devices in Assessing ART Adherence and its Association with Viral Suppression in Adolescents Living with HIV.
    J Acquir Immune Defic Syndr. 2026 May 6. doi: 10.1097/QAI.0000000000003899.
    PubMed         Abstract available
    
    
22. REDDY K, Kuhn L, Barnabas S, Molechan C, et al
    Proviral HIV-1 DNA Below Detection in Early Treated Adolescents After Prior Treatment Interruption.
    J Acquir Immune Defic Syndr. 2026 May 6. doi: 10.1097/QAI.0000000000003897.
    PubMed         Abstract available
    
    

    
    J Clin Invest

23. GAY CL, Xu Y, Weideman AMK, Shaw FR, et al
    MVA.tHIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.
    J Clin Invest. 2026 May 5:e193547. doi: 10.1172/JCI193547.
    PubMed         Abstract available
    
    
24. NIDEFFER J, Bach F, Strubbe S, Lopez L, et al
    CXCR6+CD127- Tr1 cells balance immunity and persistence in Plasmodium falciparum infection.
    J Clin Invest. 2026 May 5:e200628. doi: 10.1172/JCI200628.
    PubMed         Abstract available
    
    

    
    J Infect Dis

25. PITCHENIK AE
    A missed early signal of the HIV-tuberculosis syndemic in a 1982 MMWR report.
    J Infect Dis. 2026 May 8:jiag261. doi: 10.1093.
    PubMed        
    
    
26. PRODANUK M, Boillat-Blanco N, D'Acremont V, Fung A, et al
    Host plasma protein biomarkers for tuberculosis disease screening in febrile adults in Tanzania.
    J Infect Dis. 2026 May 6:jiag238. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

27. MCHANTAF G, Maia X, Andriantsoanirina V, Dehan O, et al
    Comparative Evaluation of the New HIV VIDAS(R) DUO AG/AB Assay With DUO Ultra on Well Characterized Participants From the HIV-1 Acute Infection French ANRS PRIMO Cohort.
    J Med Virol. 2026;98:e70953.
    PubMed         Abstract available
    
    

    
    J Virol

28. NIKOLOPOULOS N, Modis Y
    Crystal structure of HERV-K envelope glycoprotein surface subunit.
    J Virol. 2026 May 7:e0019526. doi: 10.1128/jvi.00195.
    PubMed         Abstract available
    
    
29. XIE Q, Wang Q, Noettger S, Gosalbez G, et al
    Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmission.
    J Virol. 2026 May 7:e0031426. doi: 10.1128/jvi.00314.
    PubMed         Abstract available
    
    
30. SUOMALAINEN M, Haenseler W, Kolibius J, Pluckthun A, et al
    Transcriptional transactivation turns human iPSC-derived macrophages into an adenovirus-producing cell state.
    J Virol. 2026 May 4:e0039226. doi: 10.1128/jvi.00392.
    PubMed         Abstract available
    
    

    
    Nat Med

31. JALIL EM, Veloso VG, Grinsztejn B
    Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems.
    Nat Med. 2026 May 1. doi: 10.1038/s41591-026-04373.
    PubMed        
    
    

    
    Nat Rev Immunol

32. ELAHI S
    Immune regulation by erythroid cells: how erythroid progenitor cells and mature red blood cells shape immunity.
    Nat Rev Immunol. 2026 May 5. doi: 10.1038/s41577-026-01303.
    PubMed         Abstract available
    
    

    
    Nature

33. MESNER D, Whelan MVX, Shivkumar M, Reuschl AK, et al
    HIV-1 signalling remodels nuclear pores to licence infection.
    Nature. 2026 May 6. doi: 10.1038/s41586-026-10453.
    PubMed         Abstract available
    
    

    
    PLoS Med

34. ELSBERND K, Sabi I, Jani IV, Mudenyanga C, et al
    Point-of-care early infant HIV diagnosis at birth in a pragmatic cluster-randomized trial in Mozambique and Tanzania: A comparative cost and cost-effectiveness study.
    PLoS Med. 2026;23:e1005069.
    PubMed         Abstract available
    
    
35. ARATRIKA A, Doyle CM, Johnson CC, Edun O, et al
    Trends in HIV self-testing uptake in Africa: A modeling study of population-based surveys and HIV testing program data.
    PLoS Med. 2026;23:e1004771.
    PubMed         Abstract available
    
    

    
    PLoS One

36. JANGIPOUR AFSHAR P, Yazdi-Feyzabadi V, Abdolahinia Z, Haghdoost A, et al
    Integration of HIV, Hepatitis B, and C, and sexually transmitted infections services: A scoping review of the benefits and challenges.
    PLoS One. 2026;21:e0348073.
    PubMed         Abstract available
    
    
37. CHANDE AI, Tesha NA, Sunguya B
    Factors associated with high viral load among HIV clients aged 15 years and older receiving treatment in Tanga city council, Tanzania: A facility-based cross-sectional study.
    PLoS One. 2026;21:e0348862.
    PubMed         Abstract available
    
    
38. RAMAMONJIARISOA FM, Razafiarimanga ZN, Ramaroson R
    Integrated laboratory protocol for the diagnosis of Sexually Transmitted Infections (STIs): Standardized pre-analytical procedures, rapid screening, hemagglutination, and ELISA methods for use in resource-limited settings.
    PLoS One. 2026;21:e0346598.
    PubMed         Abstract available
    
    
39. ERREGA D, Kantaris M, Deresse A, Berhanu K, et al
    Cardiovascular diseases among people living with HIV/AIDS in Ethiopia: A scoping review.
    PLoS One. 2026;21:e0348283.
    PubMed         Abstract available
    
    
40. MILTZ AR, Sewell J, Nakagawa F, Sherr L, et al
    Stigma and depression among heterosexual men and women living with HIV in the UK: Investigating a conceptual framework.
    PLoS One. 2026;21:e0343610.
    PubMed         Abstract available
    
    
41. IYER SS, Pry JM, Kapesa H, Moono M, et al
    The Asante HIV-1 Rapid Recency(R) Assay is reliable, feasible, and acceptable for use at the point-of-care in Lusaka, Zambia.
    PLoS One. 2026;21:e0346868.
    PubMed         Abstract available
    
    
42. BROWN OBE DA, Tariq S, Boffito M, Asboe D, et al
    Evaluation of the psychometric properties of the Episodic Disability Questionnaire (EDQ) among women living with HIV in the United Kingdom: A self-reported repeated measure study.
    PLoS One. 2026;21:e0336679.
    PubMed         Abstract available
    
    

    
    Science

43. SKELLY AN, Gristick HB, Li H, Gavor E, et al
    Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design.
    Science. 2026 May 7:eaec6396. doi: 10.1126/science.aec6396.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum